Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Atorvastatin 80 mg vs Lipitor 80 mg in healthy Thai volunteers (fasting, replicate crossover)
TCTR20241030002Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of atorvastatin in hypercholesterolemia and combined dyslipidaemia (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
atorvastatin
03
Conditions
hypercholesterolemiacombined dyslipidaemia
Beyond the preview
Go deeper on TCTR20241030002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20241030002.